James Moses, M.D.
NPI 1831187194 · Ophthalmology Physician · Grove City, OH
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
James Moses, M.D. is a Ophthalmology Physician provider in Grove City, OH (NPI 1831187194).
Provider details
- NPI number
- 1831187194
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 35.037237 (OH)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,092 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 403 | $117 |
| Established Patient Problem Focused Exam of Visual System92012 | 223 | $83 |
| Imaging of Optic Nerve92133 | 93 | $34 |
| Exam of Visual Field With Extended Testing92083 | 78 | $59 |
| New Patient Complete Exam of Visual System92004 | 72 | $139 |
| Removal of Cataract With Insertion of Prosthetic Lens66984 | 70 | $507 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 11 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 434 | 109 |
| Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth | 295 | 202 |
| Ketorolac Tromethamine | 223 | 153 |
| Timolol Maleate | 135 | 42 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 126 | 40 |
| Prednisolone Acetate | 92 | 79 |
| Erythromycin Basebrand: Erythromycin | 51 | 38 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$149 across 8 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-10-11
- Last updated
- 2020-07-01
- Certified
- 2020-07-01
Frequently asked questions
- What is James Moses's NPI number?
- James Moses's National Provider Identifier (NPI) is 1831187194, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is James Moses's specialty?
- James Moses is listed in the NPPES registry with a primary specialty of Ophthalmology Physician (Allopathic & Osteopathic Physicians).
- Where is James Moses located?
- James Moses's practice location on file with NPPES is 1600 Gateway Cir, Grove City, OH 43123-8650.
- What is James Moses's phone number?
- The practice phone number listed in the NPPES registry for James Moses is (614) 274-2020.
- Does James Moses accept Medicare?
- James Moses is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is James Moses's NPI active?
- Yes — James Moses's NPI (1831187194) is active in the NPPES registry as of the last update on 2020-07-01.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.